Domicilium Fund discloses major Eloxx warrant holdings
Domicilium Real Estate Fund III LP filed an initial ownership report for Eloxx Pharmaceuticals, Inc., disclosing indirect holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Domicilium Real Estate Fund III LP filed an initial ownership report for Eloxx Pharmaceuticals, Inc., disclosing indirect holdings in the company. The filing shows indirect ownership of 157,138 shares of common stock and a separate indirect position of 1,250,000 common shares.
The report also lists indirect holdings of Pre-Funded Warrants exercisable for 20,841,782 and 1,372,652 shares of common stock at an exercise price of $0.0100 per share. According to the disclosure, these Pre-Funded Warrants have no expiration date and are exercisable at any time, subject to a 4.99% beneficial ownership cap that limits exercises if they would push the holder above 4.99% of outstanding common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Footnotes (3)
- F1. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.
- F2. The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium.
- F3. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Key Figures
Key Terms
Pre-Funded Warrants financial
beneficially own financial
ten percent owner regulatory
indirectly beneficially owned financial
investment adviser financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Domicilium Real Estate Fund III LP report in its Form 3 for ELOX?
What pre-funded warrant position did Domicilium report in Eloxx (ELOX)?
Do the Eloxx (ELOX) pre-funded warrants held by Domicilium expire?
What is the 4.99% beneficial ownership cap mentioned in the Eloxx (ELOX) filing?
Who else may be deemed to beneficially own the Eloxx (ELOX) securities reported by Domicilium?
AI-generated analysis. How Rhea-AI works. Not financial advice.